XML 32 R18.htm IDEA: XBRL DOCUMENT
v3.5.0.2

Stockholders' Equity | 12 Months Ended
--- | ---
Jul. 31, 2016
Equity [Abstract] |
Shareholders' Equity | 11 — Stockholders’ Equity General The Company has authorized the issuance of 180 million shares of common stock, with a par value of $0.0001, of which 110,122,060 shares were issued and outstanding at July 31, 2016. As of July 31, 2016 and 2015, the Company had reserved 20,812,967 and 22,682,820 shares of common stock, respectively, for the issuance of options granted under the Company’s stock option plans and 989,811 and 1,097,943 shares of common stock, respectively, for the issuance of shares under the Copart, Inc. Employee Stock Purchase Plan (ESPP). The Company has authorized the issuance of five million shares of preferred stock, with a par value of $0.0001, none of which were issued or outstanding at July 31, 2016 or 2015, which have the rights and preferences as the Company’s Board of Directors shall determine, from time to time. Stock Repurchases On September 22, 2011, our Board of Directors approved a 40 million share increase in the stock repurchase program, bringing the total current authorization to 98 million shares. The repurchases may be effected through solicited or unsolicited transactions in the open market or in privately negotiated transactions. No time limit has been placed on the duration of the stock repurchase program. Subject to applicable securities laws, such repurchases will be made at such times and in such amounts as the we deem appropriate and may be discontinued at any time. For fiscal 2016 we repurchased 2,938,519 shares of our common stock at a weighted average price of $40.13 per share totaling $117.9 million. For fiscal 2015, we repurchased 231,500 shares of our common stock at a weighted average price of $36.02 per share totaling $8.3 million. For fiscal 2014, we did not repurchase any common stock. As of July 31, 2016, the total number of shares repurchased under the program was 53,456,801 and 44,543,199 shares were available for repurchase under the program. On July 9, 2015, the Company completed a modified "Dutch Auction" tender offer, or tender offer, to purchase up to 13,888,888 shares of our common stock at a price not greater than $36.00 nor less than $34.75 per share. In connection with the tender offer, we accepted for payment an aggregate of 6,254,061 shares of our common stock at a purchase price of $36.00 per share for a total value of $225.1 million. Additionally, on December 30, 2015, the Company completed a modified "Dutch Auction" tender offer, or tender offer, to purchase up to 7,317,073 shares of our common stock at a price not greater than $41.00 nor less than $38.00 per share. In connection with the tender offer, the Company accepted for payment an aggregate of 8,333,333 shares of its common stock at a purchase price of $39.00 per share for a total value of $325.0 million. The Company's directors and executive officers did not participate in the tender offers. The shares purchased as a result of the tender offers were not part of the Company's stock repurchase program. During fiscal 2016, 2015 and 2014, certain executive officers and employees exercised stock options through cashless exercises. A portion of the options exercised were net settled in satisfaction of the exercise price and federal and state minimum statutory tax withholding requirements. The Company remitted $15.0 million, $3.8 million and $0.1 million for the years ended July 31, 2016, 2015 and 2014, respectively, to the proper taxing authorities in satisfaction of the employees’ minimum statutory withholding requirements. The exercised stock options, utilizing a cashless exercise, are summarized in the following table:
Period | Options Exercised |  | Exercise Price |  | Shares Net Settled for Exercise |  | Shares Withheld for Taxes(1) |  | Net Shares to Employee |  | Share Price for Withholding |  | Tax Withholding (in 000s)
FY 2014—Q1 | 14,000 |  |  | $ | 16.43 |  |  | 7,241 |  |  | 2,519 |  |  | 4,240 |  |  | $ | 31.77 |  |  | $ | 80 |
FY 2015—Q1 | 201,333 |  |  | 19.59 |  |  | 124,621 |  |  | 35,416 |  |  | 41,296 |  |  | 31.65 |  |  | 1,121 |
FY 2015—Q3 | 139,690 |  |  | 20.27 |  |  | 76,021 |  |  | 20,656 |  |  | 43,013 |  |  | 37.27 |  |  | 770 |
FY 2015—Q4 | 200,000 |  |  | 12.02 |  |  | 66,602 |  |  | 52,158 |  |  | 81,240 |  |  | 36.08 |  |  | 1,882 |
FY 2016—Q4 | 1,130,000 |  |  | 18.64 |  |  | 410,648 |  |  | 293,152 |  |  | 426,200 |  |  | 51.30 |  |  | 15,039 |
(1) | Shares withheld for taxes are treated as a repurchase of shares for accounting purposes but do not count against the Company’s stock repurchase program.
Employee Stock Purchase Plan The ESPP provides for the purchase of up to an aggregate of 5 million shares of common stock of the Company by employees pursuant to the terms of the ESPP. The Company’s ESPP was adopted by the Board of Directors and approved by the stockholders in 1994. The ESPP was amended and restated in 2003 and again approved by the stockholders. In 2014, a new ESPP was approved by the Board of Directors and approved by the stockholders. Under the ESPP, employees of the Company who elect to participate have the right to purchase common stock at a 15% discount from the lower of the market value of the common stock at the beginning or the end of each six month offering period. The ESPP permits an enrolled employee to make contributions to purchase shares of common stock by having withheld from their salary an amount up to 10% of their compensation (which amount may be increased from time to time by the Company but may not exceed 15% of compensation). No employee may purchase more than $25,000 worth of common stock (calculated at the time the purchase right is granted) in any calendar year. The Compensation Committee of the Board of Directors administers the ESPP. The number of shares of common stock issued pursuant to the ESPP during the years ended July 31, 2016, 2015 and 2014 was 108,132; 101,015; and 81,967, respectively. As of July 31, 2016, there were 4,050,226 shares of common stock issued pursuant to the ESPP and 989,811 shares remain available for purchase under the ESPP. Stock Options In December 2007, the Company adopted the Copart, Inc. 2007 Equity Incentive Plan (Plan), presently covering an aggregate of 8.0 million shares of the Company’s common stock. The Plan provides for the grant of incentive stock options, restricted stock, restricted stock units and other equity-based awards to employees and non-qualified stock options, restricted stock, restricted stock units and other equity-based awards to employees, officers, directors and consultants at prices not less than 100% of the fair market value for incentive and non-qualified stock options, as determined by the Board of Directors at the grant date. Incentive and non-qualified stock options may have terms of up to ten years and vest over periods determined by the Board of Directors. Options generally vest ratably over a five-year period. The Plan replaced the Company’s 2001 Stock Option Plan. As of July 31, 2016, 1,360,067 shares were available for grant under the Plan. In April 2009, the Compensation Committee of the Company’s Board of Directors, subject to stockholder approval (which was subsequently obtained at the April 14, 2009 special meeting of stockholders), approved the grant to each of Willis J. Johnson, the Company’s Chairman (and then Chief Executive Officer), and A. Jayson Adair, the Company’s Chief Executive Officer (and then President), of nonqualified stock options to purchase 4,000,000 shares of the Company’s common stock at an exercise price of $15.11 per share, which equaled the closing price of the Company’s common stock on April 14, 2009, the effective date of grant. Such grants were made in lieu of any cash salary or bonus compensation in excess of $1.00 per year or the grant of any additional equity incentives for a five-year period. Each option became exercisable over five years, due to continued service by the executive, with 20% vesting on April 14, 2010, and the balance vesting ratably over the subsequent four years. Each option became fully vested due to continued service on April 14, 2014, the fifth anniversary of the date of grant. The total compensation expense recognized by the Company over the five year service period was $26.1 million per grant. The Company recognized no compensation expense in the years ended July 31, 2016 and 2015 and $7.2 million for the year ended July 31, 2014, relating to these grants. In October 2013, the Compensation Committee of the Company’s Board of Directors, subject to stockholder approval (which was subsequently obtained at the December 16, 2013 annual meeting of stockholders), approved the grant to each of A. Jayson Adair, the Company’s Chief Executive Officer, and Vincent W. Mitz, the Company’s President, of nonqualified stock options to purchase 2,000,000 and 1,500,000 shares of the Company’s common stock, respectively, at an exercise price of $35.62 per share, which equaled the closing price of the Company’s common stock on December 16, 2013, the effective date of grant. Such grants were made in lieu of any cash salary or bonus compensation in excess of $1.00 per year or the grant of any additional equity incentives for a five-year period. Each option will become exercisable over five years, subject to continued service by Mr. Adair and Mr. Mitz, with 20% vesting on April 15, 2015 and December 16, 2014, respectively, and the balance vesting monthly over the subsequent four years. Each option will become fully vested, assuming continued service, on April 15, 2019 and December 16, 2018, respectively. If, prior to a change in control, either executive’s employment is terminated without cause, then 100% of the shares subject to that executive’s stock option will immediately vest. If, upon or following a change in control, either the Company or a successor entity terminates the executive’s service without cause, or the executive resigns for good reason (as defined in the option agreement), then 100% of the shares subject to his stock option will immediately vest. On June 2, 2015, the Compensation Committee of the Company’s Board of Directors approved the amendment of each of the stand-alone stock option agreements, by and between the Company and A. Jayson Adair and Vincent W. Mitz, respectively, to remove the provision providing at times prior to a “change in control” for the immediate vesting in full of the underlying option upon an involuntary termination of Mr. Adair or Mr. Mitz, as applicable, without “cause.” The fair value of each option at the date of grant was $11.43. The total estimated compensation expense to be recognized by the Company over the five year estimated service period for these options is $40.0 million. The Company recognized $7.5 million in compensation expenses for these grants in the years ended July 31, 2016 and 2015, respectively and $4.7 million in 2014. The following table details stock-based payment compensation expense included in the company’s consolidated statements of income:
| Year Ended July 31,
(In thousands) | 2016 |  | 2015 |  | 2014
General and administrative | $ | 18,194 |  |  | $ | 15,938 |  |  | $ | 19,489 |
Yard operations | 2,670 |  |  | 2,216 |  |  | 2,610 |
Total stock-based payment compensation | $ | 20,864 |  |  | $ | 18,154 |  |  | $ | 22,099 |
There were no material compensation costs capitalized as part of the cost of an asset as of July 31, 2016 and 2015. A summary of the status of the Company’s non-vested shares and its activity during the year ended July 31, 2016 was as follows:
(In thousands, except per share amounts) | Number of Shares |  | Weighted Average Grant- date Fair Value
Non-vested shares at July 31, 2015 | 6,615 |  |  | $ | 10.48 |
Grants of non-vested shares | 432 |  |  | 10.07 |
Vested | (2,074 | ) |  | 10.12 |
Forfeitures or expirations | (162 | ) |  | 8.63 |
Non-vested shares at July 31, 2016 | 4,811 |  |  | $ | 10.66 |
Stock option activity for the year ended July 31, 2016 was as follows:
(In thousands, except per share and term data) | Shares |  | Weighted Average Exercise Price |  | Weighted Average Remaining Contractual Term (In years) |  | Aggregate Intrinsic Value
Outstanding as of July 31, 2015 | 21,011 |  |  | $ | 23.65 |  |  | 5.78 |  | $ | 261,339 |
Grants of options | 432 |  |  | 38.71 |  |  |  |  |
Exercises | (1,830 | ) |  | 19.19 |  |  |  |  |
Forfeitures or expirations | (162 | ) |  | 35.87 |  |  |  |  |
Outstanding as of July 31, 2016 | 19,451 |  |  | $ | 24.30 |  |  | 4.96 |  | $ | 508,401 |
Exercisable as of July 31, 2016 | 14,640 |  |  | $ | 20.47 |  |  | 3.91 |  | $ | 438,774 |
Vested and expected to vest as of July 31, 2016 | 19,121 |  |  | $ | 24.10 |  |  | 4.90 |  | $ | 503,601 |
As required by ASC 718, Compensation — Stock Compensation, the Company made an estimate of expected forfeitures and recognized compensation cost only for those equity awards expected to vest. The aggregate intrinsic value in the table above represents the total pretax intrinsic value (i.e., the difference between the Company’s closing stock price on the last trading day of the year ended July 31, 2016 and the exercise price, times the number of shares) that would have been received by the option holders had all option holders exercised their options on July 31, 2016. The aggregate intrinsic value of options exercised was $53.6 million, $13.4 million and $10.5 million in the years ended July 31, 2016, 2015 and 2014, respectively, and represents the difference between the exercise price of the option and the estimated fair value of the Company’s common stock on the dates exercised. As of July 31, 2016, the total compensation cost related to non-vested stock-based payment awards granted to employees under the Company’s stock option plans but not yet recognized was $45.5 million, net of estimated forfeitures. This cost will be amortized on a straight-line basis over a weighted average remaining term of 2.99 years and will be adjusted for subsequent changes in estimated forfeitures. The fair value of options vested for the years ended July 31, 2016, 2015 and 2014 was $21.0 million, $19.5 million and $15.0 million, respectively. The following table summarizes stock options outstanding and exercisable as of July 31, 2016:
(In thousands, except per share amount) | Options Outstanding |  | Options Exercisable
Range of Exercise Prices | Number |  | Weighted Average Remaining Contractual Life |  | Weighted Average Exercise Price |  | Number |  | Weighted Average Exercise Price
$13.08–$15.11 | 8,056 |  |  | 2.70 |  | $ | 15.09 |  |  | 8,056 |  |  | $ | 15.09 |
$16.38–$19.78 | 2,119 |  |  | 2.27 |  | 17.29 |  |  | 2,119 |  |  | 17.29 |
$20.56–$35.62 | 6,851 |  |  | 7.27 |  | 32.81 |  |  | 3,617 |  |  | 30.56 |
$35.72–$49.51 | 2,425 |  |  | 8.27 |  | 37.00 |  |  | 848 |  |  | 36.48 |
| 19,451 |  |  | 4.96 |  | 24.30 |  |  | 14,640 |  |  | 20.47 |

X
- References No definition available. + Details
Name: | us-gaap_EquityAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for accounts comprising shareholders' equity, comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income, and compensation-related costs for equity-based compensation. Includes, but is not limited to, disclosure of policies, compensation plan details, equity-based arrangements to obtain goods and services, deferred compensation arrangements, and employee stock purchase plan details. + References No definition available. + Details
Name: | us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration